Alma®Lasers Introduces the Ultimate Device in Face and Body Aesthetic Solutions
BUFFALO GROVE, Ill., Dec. 19, 2012 /PRNewswire/ -- Now it is possible to address tailored anti-aging treatments for the face and body with one, attractive, easy to use radiofrequency device. Alma Lasers, Inc., a provider in laser, light, and radiofrequency aesthetic and medical devices, is pleased to announce the introduction of the newest addition to their RF product portfolio; the Accent VShape.( )
Accent VShape offers physicians the complete spectrum of reliable, effective RF therapies in a single upgradable platform. Expanding from the previous generation of the Accent family, the new system boasts advanced patented technology*, improved user interface and temperature control feedback mechanisms.
Additionally, Accent VShape is currently the only RF platform to support both non-invasive and fractionated skin resurfacing solutions. With the versatility of fractionated skin resurfacing, practitioners can now address a wider array of aesthetic imperfections without the need for multiple pieces of equipment. The treatments have been noted to produce results similar to traditional fractionated CO2 treatments but with reduced risk and downtime. Furthermore, unlike other RF based technologies, the Accent VShape does not require consumables making treatments clean, efficient and economical.
"Once again Alma Lasers is an industry leader. The Accent VShape adds a powerful and efficient tool in face and body treatments leading to a higher level of patient satisfaction and improved results compared to current RF technologies," said Dr. Richard Carlino, Specialist in Plastic Surgery, PA and The Museum Spa & Laser Center, PLLC, Raleigh, NC. "The system is the only device to offer refractive, unipolar and bipolar technology in one platform presenting the most dramatic improvement of wrinkles and skin resurfacing. Alma has provided an affordable and powerful tool to the aesthetic community and I expect the product to rapidly become the first- in-class treatment for these indications."
Related PRNewswire Releases News